OR WAIT null SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
March 02, 2021
The need for real-time monitoring and control has spurred the development of new analytical tools.
January 28, 2021
The £500,000 (US$686,294)-investment in mass spectrometry support will accelerate biologics development and approval.
June 29, 2020
Enhanced sensitivity and ultra-high detection speed provide improved robustness and operability.
May 01, 2020
In this peer-reviewed article, the authors present a series of experimental studies showcasing the performance of MMS in secondary-structure biopharma characterization and compare it with conventional FTIR data.
February 01, 2020
Analytical solutions are improving for raw material testing, process development, drug product release, and more.
Complex protein structures pose analytical challenges that can be addressed by advanced mass spectrometry technologies and workflows, which can be used to comprehensively characterize them.
November 01, 2019
The following details some of the latest tools and systems available for biopharmaceutical laboratory operations.
September 01, 2019
Effective application of mass-spectrometry tools can optimize biosimilar analysis, reducing development time and cost.
August 29, 2019
Protagen Protein Services’ recently acquired Brucker Tensor II IR spectrometer significantly expands the company’s analytical capabilities.
July 01, 2019
Real-time monitoring of product- and process-related impurities remains a challenge.